- Disease: Acute COVID-19
- Study type: Observational Cohort Study, Natural History
- Study type descriptors: Prospective, Single centre
- Objective: To describe the clinical evolution of kidney transplant receipients with SARS-CoV-2 infection treated with molnupiravir and the possible interactions between molnupiravir and the immunosuppressive treatment
- Number of participants enrolled: 9
- Study enrolling from to
- Study includes follow-up for 1 month
Study Data
- Adults (18-64 years)
- Fragile population
- Hospital
- Outpatient clinic
- SARS-CoV-2
- Acute COVID-19
- Pharmacological intervention
- Antivirals
- Molnupiravir
External Links
Other information
The information was provided with the aid of the study investigators
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to